{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:11:42Z","timestamp":1792293102743,"version":"4.4.0"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s11064-018-2492-0","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T02:10:42Z","timestamp":1518055842000},"page":"214-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease"],"prefix":"10.1007","volume":"44","author":[{"given":"Simonetta","family":"Camandola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Plick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"2492_CR1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm BB, Battig K, Holmen J, Nehlig A, Zxartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83\u2013133","journal-title":"Pharmacol Rev"},{"key":"2492_CR2","first-page":"37","volume":"46","author":"AH Trivino","year":"2013","unstructured":"Trivino AH (2013) Chocolate: the story of Nahuatlism. Estudios de Cultura Nahuatl 46:37\u201387","journal-title":"Estudios de Cultura Nahuatl"},{"key":"2492_CR3","volume-title":"The coffee book: anatomy of an industry from crop to the last drop","author":"G Dicum","year":"1999","unstructured":"Dicum G, Luttinger N (1999) The coffee book: anatomy of an industry from crop to the last drop. The New Press, New York"},{"key":"2492_CR4","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1002\/1521-3773(20021202)41:23<4439::AID-ANIE4439>3.0.CO;2-6","volume":"41","author":"H Kunz","year":"2002","unstructured":"Kunz H (2002) Emil Fischer \u2013 unequalled classicist, master of organic chemistry research, and inspired trailblazer of biological chemistry. Agnew Chem Int Ed 41:4439\u20134451","journal-title":"Agnew Chem Int Ed"},{"key":"2492_CR5","first-page":"30","volume":"35","author":"JL Donovan","year":"2001","unstructured":"Donovan JL, DeVane CL (2001) A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology. Psychopharmacol Bull 35:30\u201348","journal-title":"Psychopharmacol Bull"},{"key":"2492_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/scientificamerican0715-40","volume":"313","author":"MP Mattson","year":"2015","unstructured":"Mattson MP (2015) What doesn\u2019t kill you\u2026. Sci Am 313:40\u201345","journal-title":"Sci Am"},{"key":"2492_CR7","first-page":"28","volume":"141","author":"MF Stidworthy","year":"1997","unstructured":"Stidworthy MF, Bleakley JS, Cheeseman MT, Kelly DF (1997) Chocolate poisoning in dogs. Vet Rec 141:28","journal-title":"Vet Rec"},{"key":"2492_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.6207592","volume":"226","author":"JA Nathanson","year":"1984","unstructured":"Nathanson JA (1984) Caffeine and related methylxanthines: possible naturally occurring pesticides. Science 226:184\u2013187","journal-title":"Science"},{"key":"2492_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1124\/pr.113.007757","volume":"66","author":"J Lee","year":"2014","unstructured":"Lee J, Jo DG, Park D, Chung HY, Mattson MP (2014) Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system. Pharmacol Rev 66:815\u2013868","journal-title":"Pharmacol Rev"},{"key":"2492_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/aje\/kwf119","volume":"156","author":"M Johnson-Kozlow","year":"2002","unstructured":"Johnson-Kozlow M, Kritz-Silverstein D, Barrett-Connor E, Morton D (2002) Coffee consumption and cognitive function among older adults. Am J Epidemiol 156:842\u2013850","journal-title":"Am J Epidemiol"},{"key":"2492_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JAD-2009-0920","volume":"16","author":"MH Eskelinen","year":"2009","unstructured":"Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M (2009) Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 16:85\u201391","journal-title":"J Alzheimers Dis"},{"key":"2492_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.21782","volume":"23","author":"KM Powers","year":"2008","unstructured":"Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H (2008) Combined effects of smoking, coffee, and NSAIDs on Parkinson\u2019s disease risk. Mov Disord 23:88\u201395","journal-title":"Mov Disord"},{"key":"2492_CR13","doi-asserted-by":"publisher","first-page":"e0165861","DOI":"10.1371\/journal.pone.0165861","volume":"11","author":"QP Ma","year":"2016","unstructured":"Ma QP, Huang C, Cui QY, Yang DJ, Sun K, Chen X, Li XH (2016) Meta-Analysis of the Association between Tea Intake and the Risk of Cognitive Disorders. PLoS One 11:e0165861","journal-title":"PLoS One"},{"key":"2492_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF00613933","volume":"24","author":"J Blanchard","year":"1983","unstructured":"Blanchard J, Sawers SJ (1983) The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 24:93\u201398","journal-title":"Eur J Clin Pharmacol"},{"key":"2492_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0016-5085(19)33396-7","volume":"61","author":"TE Chvasta","year":"1971","unstructured":"Chvasta TE, Cooke AR (1971) Emptying and absorption of caffeine from the human stomach. Gastroenterology 61:838\u2013843","journal-title":"Gastroenterology"},{"key":"2492_CR16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-3565(25)33447-6","volume":"224","author":"DD Tang-Liu","year":"1983","unstructured":"Tang-Liu DD, Williams RL, Reigelman S (1983) Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther 224:180\u2013185","journal-title":"J Pharmacol Exp Ther"},{"key":"2492_CR17","first-page":"43","volume-title":"Caffeine, coffee and health","author":"MJ Arnaud","year":"1993","unstructured":"Arnaud MJ (1993) Metabolism of caffeine and other components of coffee. In: Garattini S (ed) Caffeine, coffee and health. Raven, New York, pp\u00a043\u201395"},{"key":"2492_CR18","first-page":"33","volume-title":"Handbook of experimental pharmacology","author":"MJ Arnaud","year":"2011","unstructured":"Arnaud MJ (2011) Pharmocokinetics and metabolism of natural methyxanthines in animal and man. In: Fredholm BB (ed) Handbook of experimental pharmacology, vol\u00a0200. Springer, Berlin, pp\u00a033\u201392"},{"key":"2492_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/clpt.1993.63","volume":"53","author":"W Kalow","year":"1993","unstructured":"Kalow W, Tang BK (1993) The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther 53:503\u2013514","journal-title":"Clin Pharmacol Ther"},{"key":"2492_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00008571-199204000-00004","volume":"2","author":"L Gu","year":"1992","unstructured":"Gu L, Gonzalez FJ, Kalow W, Tang BK (1992) Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2:73\u201377","journal-title":"Pharmacogenetics"},{"key":"2492_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/0009-9236(95)90025-X","volume":"58","author":"NL Benowitz","year":"1995","unstructured":"Benowitz NL, Jacob P 3rd, Mayan H, Denaro C (1995) Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther 58:684\u2013691","journal-title":"Clin Pharmacol Ther"},{"key":"2492_CR22","first-page":"371","volume":"34","author":"DD Tang-Liu","year":"1981","unstructured":"Tang-Liu DD, Riegelman S (1981) Metabolism of theophylline to caffeine in adults. Res Commun Chem Pathol Pharmacol 34:371\u2013380","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"2492_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2125.1999.00890.x","volume":"47","author":"S Gates","year":"1999","unstructured":"Gates S, Miners JO (1999) Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. Br J Clin Pharmacol 47:299\u2013305","journal-title":"Br J Clin Pharmacol"},{"key":"2492_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3109\/00498259009046896","volume":"20","author":"A Lelo","year":"1990","unstructured":"Lelo A, Birkett DJ, Miners JO (1990) Mechanism of formation of 6-amino-5-(N-methylformylamino)-1-methyluracil and 3,7-dimethyluric acid from theobromine in the rat in vitro: involvementof cytochrome P-450 and a cellular thiol. Xenobiotica 20:823\u2013833","journal-title":"Xenobiotica"},{"key":"2492_CR25","volume-title":"International Agency for Research on Cancer (IARC) monographs on the evaluation of carcinogenic risks to humans: coffee, tea, mate, methylxanthines and methylglyoxal","author":"International Agency for Research on Cancer","year":"1991","unstructured":"International Agency for Research on Cancer (1991) International Agency for Research on Cancer (IARC) monographs on the evaluation of carcinogenic risks to humans: coffee, tea, mate, methylxanthines and methylglyoxal. WHO, Geneva"},{"key":"2492_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2125.1986.tb05246.x","volume":"22","author":"A Lelo","year":"1986","unstructured":"Lelo A, Birkett DJ, Robson RA, Miners JO (1986) Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol 22:177\u2013182","journal-title":"Br J Clin Pharmacol"},{"key":"2492_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0006-2944(76)90010-7","volume":"16","author":"MJ Arnaud","year":"1976","unstructured":"Arnaud MJ (1976) Identification, kinetic and quantitative study of [2-14C] and [1-Me-14C] caffeine metabolites in rat\u2019s urine by chromatographic separations. Biochem Med 16:67\u201376","journal-title":"Biochem Med"},{"key":"2492_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-3806(93)90023-4","volume":"75","author":"JM Wilkinson","year":"1993","unstructured":"Wilkinson JM, Pollard I (1993) Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine. Brain Res Dev Brain Res 75:193\u2013199","journal-title":"Brain Res Dev Brain Res"},{"key":"2492_CR29","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/0024-3205(91)90486-U","volume":"49","author":"L Stahle","year":"1991","unstructured":"Stahle L (1991) Drug distribution studies with microdialysis: I. Tissue dependent difference in recovery between caffeine and theophylline. Life Sci 49:1835\u20131842","journal-title":"Life Sci"},{"key":"2492_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jnutbio.2016.10.002","volume":"39","author":"M Yoneda","year":"2017","unstructured":"Yoneda M, Sugimoto N, Katakura M, Matsuzaki K, Tanigami H, Yachie A, Onho-Shosaku T, Shido O (2017) Theobromine up-regulates cerebral brain-derived neurotrophic factor and facilitates motor learning in mice. J Nutr Biochem 39:110\u2013116","journal-title":"J Nutr Biochem"},{"key":"2492_CR31","unstructured":"Arnaud MJ, Enslen M (1992) The role of paraxanthine in mediating physiological effects of caffeine. In: 14th international conference in coffee science, San Francisco, 14\u201319. Proceedings ASIC, Paris, pp\u00a071\u201379"},{"key":"2492_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0031-9384(87)90126-0","volume":"41","author":"ME Arnold","year":"1987","unstructured":"Arnold ME, Petros TV, Beckwith BE, Coons G, Gorman N (1987) The effects of caffeine, impulsivity, and sex on memory for word lists. Physiol Behav 41:25\u201330","journal-title":"Physiol Behav"},{"key":"2492_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/hup.218","volume":"15","author":"PA Hameleers","year":"2000","unstructured":"Hameleers PA, Van Boxtel MP, Hogervorst E, Riedel WJ, Houx PJ, Buntinx F, Jolles J (2000) Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups. Hum Psychopharmacol 15:573\u2013581","journal-title":"Hum Psychopharmacol"},{"key":"2492_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/00221300309601276","volume":"130","author":"WL Kelemen","year":"2003","unstructured":"Kelemen WL, Creeley CE (2003) State-dependent memory effects using caffeine and placebo do not extend to metamemory. J Gen Psychol 130:70\u201386","journal-title":"J Gen Psychol"},{"key":"2492_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00213-004-1898-3","volume":"176","author":"HJ Smit","year":"2004","unstructured":"Smit HJ, Gaffan EA, Rogers PJ (2004) Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology 176:412\u2013419","journal-title":"Psychopharmacology"},{"key":"2492_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.physbeh.2011.07.027","volume":"104","author":"ES Mitchell","year":"2011","unstructured":"Mitchell ES, Slettenaar M, vd Meer N, Transler C, Jans L, Quadt F, Berry M (2011) Differential contributions of theobromine and caffeine on mood, psychomotor performance and blood pressure. Physiol Behav 104:816\u2013822","journal-title":"Physiol Behav"},{"key":"2492_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/nure.12065","volume":"71","author":"A Scholey","year":"2013","unstructured":"Scholey A, Owen L (2013) Effects of chocolate on cognitive function and mood: a systematic review. Nutr Rev 71:665\u2013681","journal-title":"Nutr Rev"},{"key":"2492_CR38","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1212\/01.wnl.0000266670.35219.0c","volume":"69","author":"K Ritchie","year":"2007","unstructured":"Ritchie K, Carri\u00e8re I, de Mendonca A, Portet F, Dartigues JF, Rouaud O, Barberger-Gateau P, Ancelin ML (2007) The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology 69:536\u2013545","journal-title":"Neurology"},{"key":"2492_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/PSY.0b013e3181c92a9c","volume":"72","author":"J Corley","year":"2010","unstructured":"Corley J, Jia X, Kyle JA, Gow AJ, Brett CE, Starr JM, McNeill G, Deary IJ (2010) Caffeine consumption and cognitive function at age 70: the Lothian Birth Cohort 1936 study. Psychosom Med 72:206\u2013214","journal-title":"Psychosom Med"},{"key":"2492_CR40","volume-title":"Caffeine for the sustainment of mental task performance: formulations for military operations","author":"Institute of Medicine","year":"2001","unstructured":"Institute of Medicine (2001) Caffeine for the sustainment of mental task performance: formulations for military operations. Washington, DC: National Academy Press"},{"key":"2492_CR41","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0091-3057(03)00171-0","volume":"75","author":"MP Boxtel van","year":"2003","unstructured":"van Boxtel MP, Schmitt JA, Bosma H, Jolles J (2003) The effects of habitual caffeine use on cognitive change: a longitudinal perspective. Pharmacol Biochem Behav 75:921\u2013927","journal-title":"Pharmacol Biochem Behav"},{"key":"2492_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/sj.ejcn.1602495","volume":"61","author":"BM Gelder van","year":"2007","unstructured":"van Gelder BM, Buijsse B, Tijhuis M, Kalmijn S, Giampaoli S, Nissinen A, Kromhout D (2007) Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE study. Eur J Clin Nutr 61:226\u2013232","journal-title":"Eur J Clin Nutr"},{"key":"2492_CR43","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/HYPERTENSIONAHA.112.193060","volume":"60","author":"G Desideri","year":"2012","unstructured":"Desideri G, Kwik-Uribe C, Grassi D, Necozione S, Ghiadoni L, Mastroiacovo D, Raffaele A, Ferri L, Bocale R, Lechiara MC, Marini C, Ferri C (2012) Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: The cocoa, cognition, and aging (CoCoA) study. Hypertension 60:794\u2013801","journal-title":"Hypertension"},{"key":"2492_CR44","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3945\/ajcn.114.092189","volume":"101","author":"D Mastroiacovo","year":"2015","unstructured":"Mastroiacovo D, Kwik-Uribe C, Grassi D, Necozione S, Raffaele A, Pistacchio L, Righetti R, Bocale R, Lechiara MC, Marini C, Ferri C, Desideri G (2015) Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the cocoa, cognition, and aging (CoCoA) study\u2013a randomized controlled trial. Am J Clin Nutr 101:538\u2013548","journal-title":"Am J Clin Nutr"},{"key":"2492_CR45","first-page":"475","volume":"40","author":"B Stavric","year":"1990","unstructured":"Stavric B, Gilbert SG (1990) Caffeine metabolism: a problem in extrapolating results from animal studies to humans. Acta Parm Jugosl 40:475\u2013489","journal-title":"Acta Parm Jugosl"},{"key":"2492_CR46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0026-895X(25)15265-6","volume":"6","author":"JA Beavo","year":"1970","unstructured":"Beavo JA, Rogers NL, Crofford OB, Hardman JG, Sutherland EW, Newman EV (1970) Effects of xanthine derivatives on lipolysis and on adenosine 3\u2032,5\u2032-monophosphate phosphodiesterase activity. Mol Pharmacol 6:597\u2013603","journal-title":"Mol Pharmacol"},{"key":"2492_CR47","first-page":"93","volume-title":"Handbook of experimental pharmacology","author":"SH Francis","year":"2011","unstructured":"Francis SH, Sekhar KR, Ke H, Corbin JD (2011) Inhibition of cyclic nucleotide phosphodiesterase by methylxanthines and related compounds. In: Fredholm BB (ed) Handbook of experimental pharmacology. Springer, Berlin, pp\u00a093\u2013134"},{"key":"2492_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0003-9861(88)90010-0","volume":"267","author":"E Rousseau","year":"1988","unstructured":"Rousseau E, Ladine J, Liu QY, Meissner G (1988) Activation of the Ca2 + release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds. Arch Biochem Biophys 267:75\u201386","journal-title":"Arch Biochem Biophys"},{"key":"2492_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000139480","volume":"54","author":"W Liu","year":"1997","unstructured":"Liu W, Meissner G (1997) Structure-activity relationship of xanthines and skeletal muscle ryanodine receptor\/Ca2 + release channel. Pharmacology 54:135\u2013143","journal-title":"Pharmacology"},{"key":"2492_CR50","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1152\/jappl.2000.89.6.2312","volume":"89","author":"TJ Hawke","year":"2000","unstructured":"Hawke TJ, Allen DG, Lindinger MI (2000) Paraxanthine, a caffeine metabolite, dose dependently increases [Ca(2+)](i) in skeletal muscle. J Appl Physiol 89:2312\u20132317","journal-title":"J Appl Physiol"},{"key":"2492_CR51","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0026-895X(25)10426-4","volume":"31","author":"IN Pessah","year":"1987","unstructured":"Pessah IN, Stambuk RA, Casida JE (1987) Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides. Mol Pharmacol 31:232\u2013238","journal-title":"Mol Pharmacol"},{"key":"2492_CR52","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1124\/mol.108.048207","volume":"74","author":"S Guerreiro","year":"2008","unstructured":"Guerreiro S, Toulorge D, Hirsch E, Marien M, Sokoloff P, Michel PP (2008) Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Mol Pharmacol 74:980\u2013989","journal-title":"Mol Pharmacol"},{"key":"2492_CR53","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0021-9258(18)60316-3","volume":"237","author":"RW Butcher","year":"1962","unstructured":"Butcher RW, Sutherland EW (1962) Adenosine 3\u2032,5\u2032-phosphate in biological materials. I. Purification and properties of cyclic 3\u2032,5\u2032-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3\u2032,5\u2032-phosphate in human urine. J Biol Chem 237:1244\u20131250","journal-title":"J Biol Chem"},{"key":"2492_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.0954-6820.1985.tb01650.x","volume":"217","author":"BB Fredholm","year":"1985","unstructured":"Fredholm BB (1985) On the mechanism of action of theophylline and caffeine. Acta Med Scand 217:149\u2013153","journal-title":"Acta Med Scand"},{"key":"2492_CR55","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1073\/pnas.78.5.3260","volume":"78","author":"SH Snyder","year":"1981","unstructured":"Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci USA 78:3260\u20133264","journal-title":"Proc Natl Acad Sci USA"},{"key":"2492_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","volume":"63","author":"BB Fredholm","year":"2005","unstructured":"Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM (2005) Adenosine and brain function. Int Rev Neurobiol 63:191\u2013270","journal-title":"Int Rev Neurobiol"},{"key":"2492_CR57","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0024-3205(96)00544-9","volume":"60","author":"A Mendonca De","year":"1996","unstructured":"De Mendonca A, Ribeiro J (1996) Adenosine and neuronal plasticity. Life Sci 60:245\u2013251","journal-title":"Life Sci"},{"key":"2492_CR58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0006-8993(99)02194-0","volume":"851","author":"AR Costenla","year":"1999","unstructured":"Costenla AR, de Mendonca A, Ribeiro JA (1999) Adenosine modulates synaptic plasticity in hippocampal slices from aged rats. Brain Res 851:228\u2013234","journal-title":"Brain Res"},{"key":"2492_CR59","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/sj.bjp.0703170","volume":"129","author":"ME Yacoubi","year":"2000","unstructured":"Yacoubi ME, Ledent C, M\u00e9nard JF, Parmentier M, Costentin J, Vaugeois JM (2000) The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A2A receptors. Br J Pharmacol 129:1465\u20131473","journal-title":"Br J Pharmacol"},{"key":"2492_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ddr.1125","volume":"52","author":"A Mendonca De","year":"2001","unstructured":"De Mendonca A, Ribeiro JA (2001) Adenosine and synaptic plasticity. Drug Dev Res 52:283\u2013290","journal-title":"Drug Dev Res"},{"key":"2492_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","volume":"24","author":"TV Dunwiddie","year":"2001","unstructured":"Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31\u201355","journal-title":"Annu Rev Neurosci"},{"key":"2492_CR62","doi-asserted-by":"publisher","first-page":"S25-S34","DOI":"10.3233\/JAD-2010-091384","volume":"20","author":"AR Costenla","year":"2010","unstructured":"Costenla AR, Cunha RA, Mendonca A (2010) Caffeine, adenosine receptors, and synaptic plasticity. J Alzheimers Dis 20:S25-S34","journal-title":"J Alzheimers Dis"},{"key":"2492_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biology5010011","volume":"5","author":"CF Reichert","year":"2016","unstructured":"Reichert CF, Maire M, Schmidt C, Cajochen C (2016) Sleep-wake regulation and its impact on working memory performance: the role of adenosine. Biology 5:1\u201325 (Basel)","journal-title":"Biology"},{"key":"2492_CR64","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11302-005-0649-1","volume":"1","author":"RA Cunha","year":"2005","unstructured":"Cunha RA (2005) Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signal 1:111\u2013134","journal-title":"Purinergic Signal"},{"key":"2492_CR65","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00018-007-7051-9","volume":"64","author":"JW Daly","year":"2007","unstructured":"Daly JW (2007) Caffeine analogs: biomedical impact. Cell Mol Life Sci 64:2153\u20132169","journal-title":"Cell Mol Life Sci"},{"key":"2492_CR66","doi-asserted-by":"publisher","first-page":"H1141","DOI":"10.1152\/ajpheart.00754.2008","volume":"296","author":"JN Yang","year":"2009","unstructured":"Yang JN, Chen JF, Fredholm BB (2009) Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. Am J Physiol Heart Circ Physiol 296:H1141\u2013H1149","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2492_CR67","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jnc.13724","volume":"139","author":"RA Cunha","year":"2016","unstructured":"Cunha RA (2016) How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem 139:1019\u20131055","journal-title":"J Neurochem"},{"key":"2492_CR68","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0306-4522(99)00179-7","volume":"93","author":"T Ochiishi","year":"1999","unstructured":"Ochiishi T, Saitoh Y, Yukawa A, Saji M, Ren Y, Shirao T, Miyamoto H, Nakata H, Sekino Y (1999) High level of adenosine A1 receptor-like immunoreactivity in the CA2\/CA3a region of the adult rat hippocampus. Neuroscience 93:955\u2013967","journal-title":"Neuroscience"},{"key":"2492_CR69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0006-8993(92)90181-8","volume":"598","author":"A Arai","year":"1992","unstructured":"Arai A, Lynch G (1992) Factors regulating the magnitude of long-term potentiation induced by u pattern stimulation. Brain Res 598:173\u2013184","journal-title":"Brain Res"},{"key":"2492_CR70","doi-asserted-by":"publisher","first-page":"12025","DOI":"10.1523\/JNEUROSCI.4094-07.2007","volume":"27","author":"M Zhao","year":"2007","unstructured":"Zhao M, Choi YS, Obrietan K, Dudek SM (2007) Synaptic plasticity (and the lack thereof) in hippocampal CA2 neurons. J Neurosci 27:12025\u201312032","journal-title":"J Neurosci"},{"key":"2492_CR71","doi-asserted-by":"publisher","first-page":"16994","DOI":"10.1073\/pnas.1005362107","volume":"107","author":"SE Lee","year":"2010","unstructured":"Lee SE, Simons SB, Heldt SA, Zhao M, Schroeder JP, Vellano CP, Cowan DP, Ramineni S, Yates CK, Feng Y, Smith Y, Sweatt JD, Weinshenker D, Ressler KJ, Dudek SM, Hepler JR (2010) RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons and hippocampal-based learning and memory. Proc Natl Acad Sci USA 107:16994\u201316998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2492_CR72","doi-asserted-by":"publisher","first-page":"14080","DOI":"10.1073\/pnas.0904775106","volume":"106","author":"SB Simons","year":"2009","unstructured":"Simons SB, Escobedo Y, Yasuda R, Dudek SM (2009) Regional differences in hippocampal calcium handling provide a cellular mechanism for limiting plasticity. Proc Natl Acad Sci USA 106:14080\u201314084","journal-title":"Proc Natl Acad Sci USA"},{"key":"2492_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nn.2962","volume":"15","author":"SB Simons","year":"2012","unstructured":"Simons SB, Caruana DA, Zhao M, Dudek SM (2012) Caffeine-induced synaptic potential in hippocampal CA2 neurons. Nat Neurosci 15:23\u201325","journal-title":"Nat Neurosci"},{"key":"2492_CR74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1460-9568.2011.07719.x","volume":"34","author":"AR Costenla","year":"2011","unstructured":"Costenla AR, Di\u00f3genes MJ, Canas PM, Rodrigues RJ, Nogueira C, Maroco J, Agostinho PM, Ribeiro JA, Cunha RA, de Mendon\u00e7a A (2011) Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing. Eur J Neurosci 34:12\u201321","journal-title":"Eur J Neurosci"},{"key":"2492_CR75","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","volume":"132","author":"N Rebola","year":"2005","unstructured":"Rebola N, Canas PM, Oliveira CR, Cunha RA (2005) Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat. Neroscience 132:893\u2013903","journal-title":"Neroscience"},{"key":"2492_CR76","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0022-3565(25)20171-9","volume":"252","author":"CR Lupica","year":"1990","unstructured":"Lupica CR, Cass WA, Zahniser NR, Dunwiddie TV (1990) Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther 252:1134\u20131141","journal-title":"J Pharmacol Exp Ther"},{"key":"2492_CR77","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/sj.bjp.0701507","volume":"122","author":"RA Cunha","year":"1997","unstructured":"Cunha RA, Constantino MD, Ribeiro JA (1997) ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Br J Pharmacol 122:1279\u20131284","journal-title":"Br J Pharmacol"},{"key":"2492_CR78","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuron.2007.11.023","volume":"57","author":"N Rebola","year":"2008","unstructured":"Rebola N, Lujan R, Cunha RA, Mulle C (2008) Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron 57:121\u2013134","journal-title":"Neuron"},{"key":"2492_CR79","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/mp.2014.182","volume":"20","author":"P Li","year":"2015","unstructured":"Li P, Rial D, Canas PM, Yoo JH, Li W, Zhou X, Wang Y, van Westen GJ, Payen MP, Augusto E, Goncalves N, Tome AR, Li Z, Wu Z, Zhou Y, IJzerman A, Boyden ES, Cunha RA, Qu J, Chen JF (2015) Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory. Mol Psychiatry 20:1339\u20131349","journal-title":"Mol Psychiatry"},{"key":"2492_CR80","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1038\/ncomms11915","volume":"7","author":"S Viana da Silva","year":"2016","unstructured":"Viana da Silva S, Habert MG, Zhang P, Bethge P, Lemos C, Goncalves N, Gorlewicz A, Malezieux M, Goncalves FQ, Grosjean N, Blanchet C, Frick A, Nagert UV, Cunha RA Mulle C (2016) Early synaptic deficits in the APP\/PS1 mouse model of Alzheimer\u2019s disease involve neuronal adenosine A2A receptors. Nat Commun 7:11915","journal-title":"Nat Commun"},{"key":"2492_CR81","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1111\/bph.13180","volume":"172","author":"N Pagnussat","year":"2015","unstructured":"Pagnussat N, Almeida AS, Marques DM, Nunes F, Chenet GC, Botton PH, Mioranza S, Loss CM, Cunha RA, Porciuncula LO (2015) Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice. Br J Pharmacol 172:3831\u20133845","journal-title":"Br J Pharmacol"},{"key":"2492_CR82","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainres.2009.09.082","volume":"1303","author":"SJ Zhou","year":"2009","unstructured":"Zhou SJ, Zhu ME, Shu D, Du XP, Song XH, Wang XT, Zheng RY, Cai XH, Chen JF, He JC (2009) Preferential enhancement of working memory in mice lacking adenosine A(2A) receptors. Brain Res 1303:74\u201383","journal-title":"Brain Res"},{"key":"2492_CR83","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1101\/lm.2136011","volume":"18","author":"CJ Wei","year":"2011","unstructured":"Wei CJ, Singer P, Coelho J, Boison D, Feldon J, Yee BK, Chen JF (2011) Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning. Learn Mem 18:459\u2013474","journal-title":"Learn Mem"},{"key":"2492_CR84","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.biopsych.2013.05.003","volume":"75","author":"CJ Wei","year":"2014","unstructured":"Wei CJ, Augusto E, Gomes CA, Singer P, Wang Y, Boison D, Cunha RA, Yee BK, Chen JF (2014) Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain. Biol Psychiatry 75:855\u2013863","journal-title":"Biol Psychiatry"},{"key":"2492_CR85","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1038\/npp.2016.98","volume":"41","author":"AP Simoes","year":"2016","unstructured":"Simoes AP, Machado NJ, Goncalves N, Kaster MP, Simoes AT, Nunes A, Pereira de Almeida L, Goosens KA, Rial D, Cunha RA (2016) Adenosine A2A receptors in the amygdala control synaptic plasticity and contextual fear memory. Neuropsychopharmacology 41:2862\u20132871","journal-title":"Neuropsychopharmacology"},{"key":"2492_CR86","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neurobiolaging.2004.08.012","volume":"26","author":"RD Prediger","year":"2005","unstructured":"Prediger RD, Batista LC, Takahashi RN (2005) Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors. Neurobiol Aging 26:957\u2013964","journal-title":"Neurobiol Aging"},{"key":"2492_CR87","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00213-013-3158-x","volume":"230","author":"T Kadowaki Horita","year":"2013","unstructured":"Kadowaki Horita T, Kobayashi M, Mori A, Jenner P, Kanda T (2013) Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex. Psychopharmacol 230:345\u2013352","journal-title":"Psychopharmacol"},{"key":"2492_CR88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","volume":"203","author":"OP Dall\u2019Igna","year":"2007","unstructured":"Dall\u2019Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR (2007) Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25\u201335)-induced cognitive deficits in mice. Exp Neurol 203:241\u2013245","journal-title":"Exp Neurol"},{"key":"2492_CR89","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.expneurol.2007.11.013","volume":"210","author":"GM Cunha","year":"2008","unstructured":"Cunha GM, Canas PM, Melo CS, Hockemeyer J, M\u00fcller CE, Oliveira CR, Cunha RA (2008) Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. Exp Neurol 210:776\u2013781","journal-title":"Exp Neurol"},{"key":"2492_CR90","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","volume":"29","author":"PM Canas","year":"2009","unstructured":"Canas PM, Porci\u00fancula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA (2009) Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci 29:14741\u201314751","journal-title":"J Neurosci"},{"key":"2492_CR91","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/mp.2012.8","volume":"18","author":"VL Batalha","year":"2013","unstructured":"Batalha VL, Pego JM, Fontinha BM, Costenla AR, Valadas JS, Baqi Y, Radjainia H, Muller CE, Sebastiao AM, Lopes LV (2013) Adenosine A2a receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. Mol Psychiatry 18:320\u2013331","journal-title":"Mol Psychiatry"},{"key":"2492_CR92","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.1073\/pnas.1423088112","volume":"112","author":"MP Kaster","year":"2015","unstructured":"Kaster MP, Machado NJ, Silva HB, Nunes A, Ardais AP, Santana M, Baqi Y, Muller CE, Rodrigues AL, Porciuncula LO, Chen JF, Tome AR, Agostinho P, Canas PM, Cinha AR (2015) Caffeine acts through neuronal adenosine A2A receptors to prevent mood memory disfunction triggered by chronic stress. Proc Natl Acad Sci USA 112:7833\u20137838","journal-title":"Proc Natl Acad Sci USA"},{"key":"2492_CR93","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","volume":"18","author":"JL Albasanz","year":"2008","unstructured":"Albasanz JL, Perez S, Barrachina M, Ferrer I, Martin M (2008) Up-regulation of adenosine receptors in the frontal cortex in Alzheimer\u2019s disease. Brain Pathol 18:211\u2013219","journal-title":"Brain Pathol"},{"key":"2492_CR94","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nn.3930","volume":"18","author":"AG Orr","year":"2015","unstructured":"Orr AG, Hsiao EC, Wang MM, Ho K, Kim DH, Wang X, Guo W, Kang J, Yu GQ, Adame A, Devidze N, Dubal DB, Masliah E, Conkin BR, Mucke L (2015) Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory. Nat Neurosci 18:423\u2013434","journal-title":"Nat Neurosci"},{"key":"2492_CR95","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1528-1167.2005.01026.x","volume":"46","author":"N Rebola","year":"2005","unstructured":"Rebola N, Porciumcula LO, Lopes LV, Oliveira CR, Soares da Silva P, Cunha RA (2005) Long term effect of convulsive behavior on the density of adenosine A1 and A2A receptors in the rat cerebral cortex. Epilepsia 46:159\u2013165","journal-title":"Epilepsia"},{"key":"2492_CR96","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0014-2999(84)90034-7","volume":"101","author":"A Nehlig","year":"1984","unstructured":"Nehlig A, Lucignani G, Kadekaro M, Porrino LJ, Sokoloff L (1984) Effects of acute administration of caffeine on local cerebral glucose utilization in the rat. Eur J Pharmacol 101:91\u2013100","journal-title":"Eur J Pharmacol"},{"key":"2492_CR97","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0014-2999(86)90340-7","volume":"129","author":"A Nehlig","year":"1986","unstructured":"Nehlig A, Daval JL, Boyet S, Vert P (1986) Comparative effects of acute and chronic administration of caffeine on local cerebral glucose utilization in the conscious rat. Eur J Pharmacol 129:93\u2013103","journal-title":"Eur J Pharmacol"},{"key":"2492_CR98","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","volume":"17","author":"A Nehlig","year":"1992","unstructured":"Nehlig A, Daval JL, Debry G (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic, and psychostimulant effects. Brain Res Brain Res Rev 17:139\u2013170","journal-title":"Brain Res Brain Res Rev"},{"key":"2492_CR99","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.1228806","volume":"339","author":"GA Wright","year":"2013","unstructured":"Wright GA, Baker DD, Palmer MJ, Stabler D, Mustard JA, Power EF, Borland AM, Stevenson PC (2013) Caffeine in floral nectar enhances a pollinator\u2019s memory of reward. Science 339:1202\u20131204","journal-title":"Science"},{"key":"2492_CR100","first-page":"1192","volume":"79","author":"A Strachecka","year":"2014","unstructured":"Strachecka A, Krauze M, Olszewski K, Borsuk G, Paleolog J, Merska M, Chobotow J, Bajda M, Grzyniwicz K (2014) Unexpected strong effect of caffeine on the vitality of western honeybees (Apis mellifera) Biochemistry 79:1192\u20131201","journal-title":"Biochemistry"},{"key":"2492_CR101","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1073\/pnas.77.5.2551","volume":"77","author":"C Londos","year":"1980","unstructured":"Londos C, Cooper DM, Wolf J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Scie USA 77:2551\u20132554","journal-title":"Proc Natl Acad Scie USA"},{"key":"2492_CR102","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1471-4159.1979.tb05236.x","volume":"33","author":"D Calker van","year":"1979","unstructured":"van Calker D, Muller M, Hamprecht B (1979) Adenosine regulates via two types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33:999\u20131005","journal-title":"J Neurochem"},{"key":"2492_CR103","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.pneurobio.2007.07.005","volume":"83","author":"BB Fredholm","year":"2007","unstructured":"Fredholm BB, Chen Y, Franco R, Sitkovsky M (2007) Aspects of the general biology of adenosine A2A signaling. Prog Neurobiol 83:263\u2013276","journal-title":"Prog Neurobiol"},{"key":"2492_CR104","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/BF00501365","volume":"316","author":"TV Dunwiddie","year":"1981","unstructured":"Dunwiddie TV, Hoffer BJ, Fredholm BB (1981) Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. Naunyn Schmiedebergs Arch Pharmacol 316:326\u2013330","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2492_CR105","first-page":"H820-826","volume":"259","author":"GE Kirsch","year":"1990","unstructured":"Kirsch GE, Codina J, Birnbaumer L, Brown AM (1990) Coupling of ATP-sensitive K + channels to A1receptors by G proteins in rat ventricular myocytes. Am J Physiol 259:H820-826","journal-title":"Am J Physiol"},{"key":"2492_CR106","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0896-6273(92)90244-8","volume":"9","author":"M Scanziani","year":"1992","unstructured":"Scanziani M, Capogna M, Gahwiler BH, Thompson SM (1992) Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus. Neuron 9:919\u2013927","journal-title":"Neuron"},{"key":"2492_CR107","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/B978-0-12-801022-8.00012-X","volume":"119","author":"JF Chen","year":"2014","unstructured":"Chen JF (2014) Adenosine receptor control of cognition in normal and disease. Int Rev Neurobiol 119:257\u2013307","journal-title":"Int Rev Neurobiol"},{"key":"2492_CR108","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.1016\/S0021-9258(17)37127-2","volume":"269","author":"M Faure","year":"1994","unstructured":"Faure M, Voyno-Yasenetskaya TA, Bourne HR (1994) cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269:7851\u20137854","journal-title":"J Biol Chem"},{"key":"2492_CR109","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/syn.20146","volume":"57","author":"L Gimenez-Llort","year":"2005","unstructured":"Gimenez-Llort L, Masino SA, Diao L, Fernandez-Teruel A, Tobena A, Halldner L et al (2005) Mice lacking the adenosine A(1) receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly. Synapse 57:8\u201316","journal-title":"Synapse"},{"key":"2492_CR110","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1523\/JNEUROSCI.4260-04.2005","volume":"25","author":"M Kukley","year":"2005","unstructured":"Kukley M, Schwan M, Fredholm BB, Dietrich D (2005) The role of extracellular adenosine in regulating mossy fiber synaptic plasticity. J Neurosci 25:2832\u20132837","journal-title":"J Neurosci"},{"key":"2492_CR111","doi-asserted-by":"publisher","first-page":"14397","DOI":"10.1073\/pnas.1835831100","volume":"100","author":"KA Moore","year":"2003","unstructured":"Moore KA, Nicoll RA, Schmitz D (2003) Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc Natl Acad Scie USA 100:14397\u201314402","journal-title":"Proc Natl Acad Scie USA"},{"key":"2492_CR112","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1523\/JNEUROSCI.5761-10.2011","volume":"31","author":"C Florian","year":"2011","unstructured":"Florian C, Vecsey CG, Halassa MM, Haydon PG, Abel T (2011) Astrocyte-derived adenosine and A1 receptor activity contribute to sleep loss-induced deficits in hippocampal synaptic plasticity and memory in mice. J Neurosci 31:6956\u20136962","journal-title":"J Neurosci"},{"key":"2492_CR113","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1523\/JNEUROSCI.0148-10.2010","volume":"30","author":"G Lu","year":"2010","unstructured":"Lu G, Zhou QX, Kang S, Li QL, Zhai LC, Chen JD et al (2010) Chronic morphine treatment impaired hippocampal long-term potentiation and spatial memory via accumulation of extracellular adenosine acting on adenosine a1 receptors. J Neurosci 30:5058\u20135070","journal-title":"J Neurosci"},{"key":"2492_CR114","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.1460-9568.2002.02122.x","volume":"16","author":"L Gimenez-Llort","year":"2002","unstructured":"Gimenez-Llort L, Fernandez-Teruel A, Escorihuela RM, Fredholm BB, Tobena A, Pekny M et al (2002) Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur J Neurosci 16:547\u2013550","journal-title":"Eur J Neurosci"},{"key":"2492_CR115","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0166-4328(03)00108-6","volume":"145","author":"UE Lang","year":"2003","unstructured":"Lang UE, Lang F, Ricther K, Vallon V, Lipp HP, Schermann J et al (2003) Emotional instability but intact spatial cognition in adenosine receptor knock out mice. Behav Brain Res 145:179\u2013188","journal-title":"Behav Brain Res"},{"key":"2492_CR116","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/BF02246579","volume":"123","author":"N Hooper","year":"1996","unstructured":"Hooper N, Fraser C, Stone TW (1996) Effects of purine analogues on spontaneous alterations in mice. Psycopharmacology 123:250\u2013257","journal-title":"Psycopharmacology"},{"key":"2492_CR117","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1124\/mol.58.4.771","volume":"58","author":"B Kull","year":"2000","unstructured":"Kull B, Svenningsson P, Fredholm BB (2000) Adenosine A2A receptors are co-localized with and activate Golf in rat striatum. Mol Pharmacol 58:771\u2013777","journal-title":"Mol Pharmacol"},{"key":"2492_CR118","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0092-8674(94)90394-8","volume":"79","author":"DA Frank","year":"1994","unstructured":"Frank DA, Greenberg ME (1994) CREB: a mediator of long-term memory from mollusks to mammals. Cell 79:5\u20138","journal-title":"Cell"},{"key":"2492_CR119","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrd1061","volume":"2","author":"T Tully","year":"2003","unstructured":"Tully T, Bourtchouladze R, Scott R, Tallman J (2003) Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2:267\u2013277","journal-title":"Nat Rev Drug Discov"},{"key":"2492_CR120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-6606-5-14","volume":"5","author":"ER Kandel","year":"2012","unstructured":"Kandel ER (2012) The molecular biology of memory; cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB. Mol Brain 5:14","journal-title":"Mol Brain"},{"key":"2492_CR121","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1046\/j.1471-4159.1996.67010374.x","volume":"67","author":"AK Gubitz","year":"1996","unstructured":"Gubitz AK, Widdowson L, Kurokawa M, Kirkpatrick KA, Richardson PJ (1996) Dual signaling by the adenosine A2A receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals. J Neurochem 67:374\u2013381","journal-title":"J Neurochem"},{"key":"2492_CR122","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0024-3205(00)00923-1","volume":"68","author":"RA Cunha","year":"2000","unstructured":"Cunha RA, Ribeiro JA (2000) ATP as a presynaptic modulator. Life Sci 68:119\u2013137","journal-title":"Life Sci"},{"key":"2492_CR123","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/S0028-3908(99)00237-3","volume":"39","author":"RA Cunha","year":"2000","unstructured":"Cunha RA, Ribeiro JA (2000) Purinergic modulation of [3H] GABA release from rat hippocampal nerve terminals. Neuropharmacol 39:1156\u20131167","journal-title":"Neuropharmacol"},{"key":"2492_CR124","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1124\/mol.108.047472","volume":"74","author":"PA Vidi","year":"2008","unstructured":"Vidi PA, Chemel BR, Hu CD, Watts VJ (2008) Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells. Mol Pharmacol 74:544\u2013551","journal-title":"Mol Pharmacol"},{"key":"2492_CR125","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","volume":"26","author":"F Ciruela","year":"2006","unstructured":"Ciruela F, Casado V, Rodrigues RJ, Lujan R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortes A, Canela EI, Lopez-Gimenez JF, Milligan G, Lluis C, Cunha RA, Ferre S, Franco R (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26:2080\u20132087","journal-title":"J Neurosci"},{"key":"2492_CR126","doi-asserted-by":"publisher","first-page":"18091","DOI":"10.1074\/jbc.M107731200","volume":"277","author":"J Hillion","year":"2002","unstructured":"Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J, Canela EI, Zoli M, Agnati LF, Ibanez CF, Lluis C, Franco R, Ferre S, Fuxe K (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277:18091\u201318097","journal-title":"J Biol Chem"},{"key":"2492_CR127","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1124\/mol.104.003376","volume":"67","author":"M Torvinen","year":"2005","unstructured":"Torvinen M, Marcellino D, Canals M, Agnati LF, Lluis C, Franco R, Fuxe K (2005) Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A\/D3 heteromeric complexes. Mol Pharmacol 67:400\u2013407","journal-title":"Mol Pharmacol"},{"key":"2492_CR128","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0304-3940(02)00179-9","volume":"324","author":"Z Diaz-Cabiale","year":"2002","unstructured":"Diaz-Cabiale Z, Vivo M, Del Arco A, O\u2019Connor WT, Harte MK, Muller CE, Martinez E, Popoli P, Fuxe K, Ferre S (2002) Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors. Neurosci Lett 324:154\u2013158","journal-title":"Neurosci Lett"},{"key":"2492_CR129","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/sj.npp.1301375","volume":"32","author":"P Carriba","year":"2007","unstructured":"Carriba P, Ortiz O, Patkar K, Justinova Z, Stroik J, Themann A, Muller C, Woods AS, Hope BT, Ciruela F, Casado V, Canela EI, Lluis C, Goldberg SR, Moratalla R, Franco R, Ferre S (2007) Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32:2249\u20132259","journal-title":"Neuropsychopharmacology"},{"key":"2492_CR130","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1073\/pnas.061020198","volume":"98","author":"FS Lee","year":"2001","unstructured":"Lee FS, Chao MV (2001) Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci USA 98:3555\u20133560","journal-title":"Proc Natl Acad Sci USA"},{"key":"2492_CR131","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1476-5381.2009.00157.x","volume":"158","author":"AM Sebastiao","year":"2009","unstructured":"Sebastiao AM, Ribeiro JA (2009) Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection. Br J Pharmacol 158:15\u201322","journal-title":"Br J Pharmacol"},{"key":"2492_CR132","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/978-3-540-89615-9_16","volume":"193","author":"AM Sebastiao","year":"2009","unstructured":"Sebastiao AM, Ribeiro JA (2009) Adenosine receptors and the central nervous system. Hand Exp Pharmacol 193:471\u2013534","journal-title":"Hand Exp Pharmacol"},{"key":"2492_CR133","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1196\/annals.1418.005","volume":"1144","author":"MP Mattson","year":"2008","unstructured":"Mattson MP (2008) Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci 1144:97\u2013112. https:\/\/doi.org\/10.1196\/annals.1418.005","journal-title":"Ann N Y Acad Sci"},{"key":"2492_CR134","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1523\/JNEUROSCI.4454-03.2004","volume":"24","author":"MJ Diogenes","year":"2004","unstructured":"Diogenes MJ, Fernandes CC, Sebastiao AM, Ribeiro JA (2004) Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci 24:2905\u20132913","journal-title":"J Neurosci"},{"key":"2492_CR135","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.neuropharm.2008.01.011","volume":"54","author":"BM Fontinha","year":"2008","unstructured":"Fontinha BM, Diogenes MJ, Ribeiro JA, Sebastiao AM (2008) Enhancement of long-termpotentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine. Neuropharmacology 54:924\u2013933","journal-title":"Neuropharmacology"},{"key":"2492_CR136","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","volume":"28","author":"MR Domenici","year":"2007","unstructured":"Domenici MR, Scattoni ML, Martire A, Lastoria G, Potenza RL, Borioni A, Venerosi A, Calamandrei G, Popoli P (2007) Behavioral and electrophysiological effects of the adenosine receptor antagonist SCH 58261 in R6\/2 Huntington\u2019s disease mice. Neurobiol Dis 28:197\u2013205","journal-title":"Neurobiol Dis"},{"key":"2492_CR137","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/hipo.20894","volume":"22","author":"RB Dias","year":"2012","unstructured":"Dias RB, Ribeiro JA, Sabastiao AM (2012) Enhancement of AMPA currents and GluR1 membrane expression through PKA-coupled adenosine A2A receptors. Hippocampus 22:276\u2013291","journal-title":"Hippocampus"},{"key":"2492_CR138","volume-title":"Handbook of experimental pharmacology","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB (2011) Handbook of experimental pharmacology, vol\u00a0200. Springer, Berlin"},{"key":"2492_CR139","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.1984.03340370043028","volume":"251","author":"EM Laska","year":"1984","unstructured":"Laska EM, Sunshine A, Mueller F, Elvers WB, Siegel C, Rubin A (1984) Caffeine as an analgesic adjuvant. JAMA 251:1711\u20131718","journal-title":"JAMA"},{"key":"2492_CR140","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1748-1716.1978.tb06062.x","volume":"102","author":"BB Fredholm","year":"1978","unstructured":"Fredholm BB (1978) effect of adenosine, adenosine analogues, and drugs inhibiting adenosine inactivation on lipolysis in rat fat cells. Acta Physiol Scand 102:191\u2013198","journal-title":"Acta Physiol Scand"},{"key":"2492_CR141","doi-asserted-by":"crossref","first-page":"863","DOI":"10.33549\/physiolres.931467","volume":"58","author":"T Szkudelski","year":"2009","unstructured":"Szkudelski T, Szkudelski K, Nogowski L (2009) Effect of adenosine a1 receptor antagonism on lpogenesis and lipolysis in isolated rat adipocytes. Physiol Res 58:863\u2013871","journal-title":"Physiol Res"},{"key":"2492_CR142","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jama.294.1.97","volume":"294","author":"RM Dam van","year":"2005","unstructured":"van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes; a systematic review. JAMA 294:97\u2013104","journal-title":"JAMA"},{"key":"2492_CR143","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/mds.870070407","volume":"7","author":"FJ Jime\u00b4nez-Jime\u00b4nez","year":"1992","unstructured":"Jime\u00b4nez-Jime\u00b4nez FJ, Mateo D, Gime\u00b4nez-Roldan S (1992) Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson\u2019s disease: a case-control study. Mov Disord 7:339\u2013344","journal-title":"Mov Disord"},{"key":"2492_CR144","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ije\/26.2.328","volume":"26","author":"W Hellenbrand","year":"1997","unstructured":"Hellenbrand W, Seidler A, Robra B-P et al (1997) Smoking and Parkinson\u2019s disease: a case control study in Germany. Int J Epidemiol 26:328\u2013339","journal-title":"Int J Epidemiol"},{"key":"2492_CR145","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/1531-8257(199901)14:1<28::AID-MDS1007>3.0.CO;2-O","volume":"14","author":"P-A Fall","year":"1999","unstructured":"Fall P-A, Frederikson M, Axelson O, Grane\u00b4rus A-K (1999) Nutritional and occupational factors influencing the risk of Parkinson\u2019s disease: a case-control study in southeastern Sweden. Mov Disord 14:28\u201337","journal-title":"Mov Disord"},{"key":"2492_CR146","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","volume":"283","author":"GW Ross","year":"2000","unstructured":"Ross GW, Abbott RD, Petrovitch H (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674\u20132679","journal-title":"JAMA"},{"key":"2492_CR147","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ana.1052","volume":"50","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC (2001) Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Ann Neurol 50:56\u201363","journal-title":"Ann Neurol"},{"key":"2492_CR148","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/STROKEAHA.113.003131","volume":"45","author":"SC Larsson","year":"2014","unstructured":"Larsson SC (2014) Coffee, tea, and cocoa and risk of stroke. Stroke 45:309\u2013314","journal-title":"Stroke"},{"key":"2492_CR149","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/hup.991","volume":"24","author":"AP Smith","year":"2009","unstructured":"Smith AP (2009) Caffeine, cognitive failures and health in a non-working community sample. Hum Psychopharmacol 24:29\u201334","journal-title":"Hum Psychopharmacol"},{"key":"2492_CR150","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/mnfr.201500620","volume":"60","author":"G Grosso","year":"2016","unstructured":"Grosso G, Micek A, Castellano S, Pajak A, Galvano F (2016) Coffee, tea, caffeine and risk of depression: a systematic review and dose-response meta-analysis of observational studies. Mol Nutr Food Res 60:223\u2013234","journal-title":"Mol Nutr Food Res"},{"key":"2492_CR151","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/archinte.1996.00440050067008","volume":"116","author":"I Kawachi","year":"1996","unstructured":"Kawachi I, Willett WC, Colditz GA, Stampfer MJ, Speizer FE (1996) A prospective study of coffee drinking and suicide in women. Arch Intern Med 116:521\u2013525","journal-title":"Arch Intern Med"},{"key":"2492_CR152","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/sj.jcbfm.9600539","volume":"28","author":"KT Sachse","year":"2008","unstructured":"Sachse KT, Jackson EK, Wisniewski SR, Gillespie DG, Puccio AM, Clark RS, Dixon CE, Kochanek PM (2008) Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans. J Cereb Blood Flow Metab 28:395\u2013401","journal-title":"J Cereb Blood Flow Metab"},{"key":"2492_CR153","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3233\/JAD-150374","volume":"47","author":"M Travassos","year":"2015","unstructured":"Travassos M, Santana J, Baldeiras I, Tsolaki M, Gkatzima O, Sermin G, Yener GG et al (2015) does caffeine consumption modify cerebrospinal fluid amyloid-b levels in patients with Alzheimer\u2019s disease? J Alzheimers Dis 47:1069\u20131078","journal-title":"J Alzheimers Dis"},{"key":"2492_CR154","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF02246949","volume":"110","author":"MJ Jarvis","year":"1993","unstructured":"Jarvis MJ (1993) Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology 110:45\u201352","journal-title":"Psychopharmacology"},{"key":"2492_CR155","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.10277","volume":"52","author":"MA Hern\u00e1n","year":"2002","unstructured":"Hern\u00e1n MA, Takkouche B, Caama\u00f1o-Isorna F, Gestal-Otero JJ (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease. Ann Neurol 52:276\u2013284","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"2492_CR156","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JAD-2010-091525","volume":"20","author":"J Costa","year":"2010","unstructured":"Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A (2010) Caffeine exposure and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis 20(Suppl):221\u2013238","journal-title":"J Alzheimers Dis"},{"key":"2492_CR157","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/ggi.12123","volume":"14","author":"H Qi","year":"2014","unstructured":"Qi H, Li S (2014) Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson\u2019s disease. Geriatr Gerontol Int 14:430\u2013439","journal-title":"Geriatr Gerontol Int"},{"key":"2492_CR158","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","volume":"60","author":"A Ascherio","year":"2003","unstructured":"Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE (2003) Caffeine, postmenopausal estrogen, and risk of Parkinson\u2019s disease. Neurology 60:790\u2013795","journal-title":"Neurology"},{"key":"2492_CR159","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/aje\/kwh312","volume":"160","author":"A Ascherio","year":"2004","unstructured":"Ascherio A, Weisskopf MG, O\u2019Reilly EJ, McCullough ML, Calle EE, Rodriguez C, Thun MJ (2004) Coffee consumption, gender, and Parkinson\u2019s disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol 160:977\u2013984","journal-title":"Am J Epidemiol"},{"key":"2492_CR160","first-page":"603","volume":"95","author":"RV Patwardhan","year":"1980","unstructured":"Patwardhan RV, Desmond PV, Johnson RF, Schenker S (1980) Impaired elimination of caffeine by oral contraceptive steroids. J Lab Clin Med 95:603\u2013608","journal-title":"J Lab Clin Med"},{"key":"2492_CR161","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/BF00544361","volume":"28","author":"DR Abernethy","year":"1985","unstructured":"Abernethy DR, Todd EL (1985) Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 28:425\u2013428","journal-title":"Eur J Clin Pharmacol"},{"key":"2492_CR162","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1523\/JNEUROSCI.3008-05.2006","volume":"26","author":"K Xu","year":"2006","unstructured":"Xu K, Xu Y, Brown-Jermyn D, Chen JF, Ascherio A, Dluzen DE, Schwarzschild MA (2006) Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. J Neurosci 26:535\u2013541","journal-title":"J Neurosci"},{"key":"2492_CR163","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.neuroscience.2010.02.020","volume":"167","author":"K Xu","year":"2010","unstructured":"Xu K, Xu YH, Chen JF, Schwarzschild MA (2010) Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson\u2019s Disease. Neuroscience 167:475\u2013481","journal-title":"Neuroscience"},{"key":"2492_CR164","first-page":"1","volume":"21","author":"JF Chen","year":"2001","unstructured":"Chen JF, Xu K, Petzer JP, Staal R, X YJ, Beilstein M, Sonsalla PK, Caatagnoli K, Castagnoli N, Schwarzschild MA (2001) Neuroprotection by caffeine and A2a adenosine receptor inactivation in a model of Parkinson\u2019s disease. J Neurosci 21:1\u20136","journal-title":"J Neurosci"},{"key":"2492_CR165","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1046\/j.0022-3042.2001.00694.x","volume":"80","author":"K Ikeda","year":"2002","unstructured":"Ikeda K, Kurokawa M, Aoyama S, Kuwana Y (2002) Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson\u2019s disease. J Neurochem 80:262\u2013270","journal-title":"J Neurochem"},{"key":"2492_CR166","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jns.2006.05.003","volume":"242","author":"A Kalda","year":"2006","unstructured":"Kalda A, Yu L, Oxtas E, Chen JF (2006) Novel neuroprotection by caffeine and adenosine A2A receptor antagonists in animal models of Parkinson\u2019s disease. J Neurol Sci 242:9\u201315","journal-title":"J Neurol Sci"},{"key":"2492_CR167","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1468-1331.2002.00421.x","volume":"9","author":"L Maia","year":"2002","unstructured":"Maia L, de Mendon\u00e7a A (2002) Does caffeine intake protect from Alzheimer\u2019s disease? Eur J Neurol 9:377\u2013382","journal-title":"Eur J Neurol"},{"key":"2492_CR168","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/070674370404900202","volume":"49","author":"J Lindsay","year":"2004","unstructured":"Lindsay J, Sykes E, McDowell I, Verreault R, Laurin D (2004) More than the epidemiology of Alzheimer\u2019s disease: contributions of the Canadian Study of Health and Aging. Can J Psychiatry 49:83\u201391","journal-title":"Can J Psychiatry"},{"key":"2492_CR169","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","volume":"142","author":"GW Arendash","year":"2006","unstructured":"Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J (2006) Caffeine protects Alzheimer\u2019s mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142:941\u2013952","journal-title":"Neuroscience"},{"key":"2492_CR170","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3233\/JAD-2009-1087","volume":"17","author":"GW Arendash","year":"2009","unstructured":"Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H (2009) Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer\u2019s disease mice. J Alzheimers Dis 17:661\u2013680","journal-title":"J Alzheimers Dis"},{"key":"2492_CR171","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/j.foodchem.2012.04.148","volume":"135","author":"YF Chu","year":"2012","unstructured":"Chu YF, Chang WH, Black RM, Liu JR, Sompol P, Chen Y, Wei H, Zhao Q, Cheng IH (2012) Crude caffeine reduces memory impairment and amyloid \u03b2(1\u201342) levels in an Alzheimer\u2019s mouse model. Food Chem 135:2095\u20132102","journal-title":"Food Chem"},{"key":"2492_CR172","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.neurobiolaging.2014.03.027","volume":"35","author":"C Laurent","year":"2014","unstructured":"Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, Demeyer D, Carrier S, Schneider M, Hamdane M, Muller CE, Bucee L, Blum D (2014) Beneficial effects of caffeine in a transgenic model of Alzheimer\u2019s disease-like tau pathology. Neurobiol Aging 35:2079\u20132090","journal-title":"Neurobiol Aging"},{"key":"2492_CR173","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/mp.2014.151","volume":"21","author":"C Laurent","year":"2016","unstructured":"Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D\u2019Hooge R, Sergeant N, Hamdane M, Humez S, M\u00fcller CE, Lopes LV, Bu\u00e9e L, Blum D (2016) A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol Psychiatry 21:97\u2013107","journal-title":"Mol Psychiatry"},{"key":"2492_CR174","doi-asserted-by":"publisher","first-page":"S51-62","DOI":"10.3233\/JAD-2010-091261","volume":"20","author":"DA Pelligrino","year":"2010","unstructured":"Pelligrino DA, Xu HL, Vetri F (2010) Caffeine and the control of cerebral hemodynamics. J Alzheimers Dis 20:S51-62","journal-title":"J Alzheimers Dis"},{"key":"2492_CR175","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuropharm.2012.06.026","volume":"64","author":"EB Klaassen","year":"2013","unstructured":"Klaassen EB, de Groot RH, Evers EA, Snel J, Veerman EC, Ligtenberg AJ, Jolles J, Veltman DJ (2013) The effect of caffeine on working memory load-related brain activation in middle-aged males. Neuropharmacology 64:160\u2013167","journal-title":"Neuropharmacology"},{"key":"2492_CR176","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.neuroimage.2007.08.037","volume":"39","author":"F Koppelstaetter","year":"2007","unstructured":"Koppelstaetter F, Poeppel TD, Siedentopf CM, Ischebeck A, Verius M, Haala I, Mottaghy FM, Rhomberg P, Golaszewski S, Gotwald T, Lorenz IH, Kolbitsch C, Felber S, Krause BJ (2007) Does caffeine modulate verbal working memory processes? An fMRI study. Neuroimage 39:492\u2013499","journal-title":"Neuroimage"},{"key":"2492_CR177","doi-asserted-by":"crossref","unstructured":"Haller S, Rodriguez C, Moser D, Toma S, Hofmeister J, Sinanaj I, Van De Ville D, Giannakopoulos P, Lovblad KO (2013) Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: a BOLD and perfusion MRI study. Neuroscience 10364\u201310371","DOI":"10.1016\/j.neuroscience.2013.07.021"},{"key":"2492_CR178","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2202-10-110","volume":"30","author":"ME Han","year":"2009","unstructured":"Han ME, Kim HJ, Lee YS, Kim DH, Choi JT, Pan CS, Yoon S, Baek SY, Kim BS, Kim JB, Oh SO (2009) Regulation of cerebrospinal fluid production by caffeine consumption. BMC Neurosci 30:110","journal-title":"BMC Neurosci"},{"key":"2492_CR179","doi-asserted-by":"crossref","first-page":"617420","DOI":"10.4061\/2011\/617420","volume":"2011","author":"P Wostyn","year":"2011","unstructured":"Wostyn P, Van Dam D, Audenaert K, De Deyn PP (2011) Increased cerebrospinal fluid production as a possible mechanism underlying Caffeine\u2019s protective effect against Alzheimer\u2019s disease. Int J Alzheimers Dis. 2011:617420","journal-title":"Int J Alzheimers Dis"},{"key":"2492_CR180","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/mp.2014.107","volume":"20","author":"MC Cornelis","year":"2015","unstructured":"Coffee and Caffeine Genetics Consortium, Cornelis MC, Byrne EM, et al. (2015) Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry. 20:647\u2013656","journal-title":"Mol Psychiatry"},{"key":"2492_CR181","first-page":"5472","volume":"25","author":"MC Cornelis","year":"2016","unstructured":"Cornelis MC, Kacprowski T, Menni C et al (2016) Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet 25:5472\u20135482","journal-title":"Hum Mol Genet"},{"key":"2492_CR182","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/JAD-2012-112189","volume":"30","author":"TM Do","year":"2012","unstructured":"Do TM, Noel-Hudson MS, Ribes S, Besengez C, Smirnova M, Cisternino S, Buyse M, Calon F, Chimini G, Chacun H, Scherrmann JM, Farinotti R, Bourasset F (2012) ABCG2- and ABCG4-mediated efflux of amyloid-\u03b2 peptide 1\u201340 at the mouse blood-brain barrier. J Alzheimers Dis 30:155\u2013166","journal-title":"J Alzheimers Dis"},{"key":"2492_CR183","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2045-8118-10-13","volume":"10","author":"W Zhang","year":"2013","unstructured":"Zhang W, Xiong H, Callaghan D, Liu H, Jones A, Pei K, Fatehi D, Brunette E, Stanimirovic D (2013) Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging. Fluids Barriers CNS 10:13. https:\/\/doi.org\/10.1186\/2045-8118-10-13","journal-title":"Fluids Barriers CNS"},{"key":"2492_CR184","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/MOL.0000000000000155","volume":"26","author":"A Raimondo","year":"2015","unstructured":"Raimondo A, Rees MG, Gloyn AL (2015) Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism. Curr Opin Lipidol 26:88\u201395. https:\/\/doi.org\/10.1097\/MOL.0000000000000155","journal-title":"Curr Opin Lipidol"},{"key":"2492_CR185","doi-asserted-by":"publisher","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz M, Johnson T, Sanna S et al (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5:e1000504","journal-title":"PLoS Genet"},{"key":"2492_CR186","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm4074","volume":"16","author":"Y Wang","year":"2015","unstructured":"Wang Y, Viscarra J, Kim SJ, Sul HS (2015) Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Biol 16:678\u2013689","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2492_CR187","doi-asserted-by":"crossref","unstructured":"Camandola S, Mattson MP (2017) Brain metabolism in health, aging, and neurodegeneration.EMBO J. 2017 Jun 1;36(11):1474\u20131492","DOI":"10.15252\/embj.201695810"},{"key":"2492_CR188","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrd3366","volume":"10","author":"AH Nagahara","year":"2011","unstructured":"Nagahara AH, Tuszynski MH (2011) Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 10:209\u2013219","journal-title":"Nat Rev Drug Discov"},{"key":"2492_CR189","doi-asserted-by":"publisher","first-page":"11426","DOI":"10.1523\/JNEUROSCI.1880-09.2009","volume":"29","author":"X Yang","year":"2009","unstructured":"Yang X, Zou J, Hyde DR, Davidson LA, Wei X (2009) Stepwise maturation of apicobasal polarity of the neuroepithelium is essential for vertebrate neurulation. J Neurosci 29:11426\u201311440","journal-title":"J Neurosci"},{"key":"2492_CR190","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1523\/JNEUROSCI.19-11-04189.1999","volume":"19","author":"K Jo","year":"1999","unstructured":"Jo K, Derin R, Li M, Bredt DS (1999) Characterization of MALS\/Velis-1, -2, and \u2013 3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95\/NMDA receptor postsynaptic complex. J Neurosci 19:4189\u20134199","journal-title":"J Neurosci"},{"key":"2492_CR191","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1093\/emboj\/21.10.2332","volume":"21","author":"C B\u00e9camel","year":"2002","unstructured":"B\u00e9camel C, Alonso G, Gal\u00e9otti N, Demey E, Jouin P, Ullmer C, Dumuis A, Bockaert J, Marin P (2002) Synaptic multiprotein complexes associated with 5-HT(2C) receptors: a proteomic approach. EMBO J 21:2332\u20132342","journal-title":"EMBO J"},{"key":"2492_CR192","doi-asserted-by":"publisher","first-page":"19051","DOI":"10.1074\/jbc.M400284200","volume":"279","author":"D Leonoudakis","year":"2004","unstructured":"Leonoudakis D, Conti LR, Radeke CM, McGuire LM, Vandenberg CA (2004) A multiprotein trafficking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifier Kir2 potassium channels. J Biol Chem 279:19051\u201319063","journal-title":"J Biol Chem"},{"key":"2492_CR193","doi-asserted-by":"publisher","first-page":"15353","DOI":"10.1038\/ncomms15353","volume":"8","author":"AT Lu","year":"2017","unstructured":"Lu AT, Hannon E, Levine ME, Crimmins EM, Lunnon K, Mill J, Geschwind DH, Horvath S (2017) Genetic architecture of epigenetic and neuronal ageing rates in human brain regions. Nat Commun 8:15353","journal-title":"Nat Commun"},{"key":"2492_CR194","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.neubiorev.2013.06.013","volume":"37","author":"AN Sokolov","year":"2013","unstructured":"Sokolov AN, Pavlova MA, Klosterhalfen S, Enck P (2013) Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior. Neurosci Biobehav Rev 37:2445\u20132453","journal-title":"Neurosci Biobehav Rev"},{"key":"2492_CR195","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3233\/JAD-140981","volume":"44","author":"JM Walker","year":"2015","unstructured":"Walker JM, Klakotskaia D, Ajit D, Weisman GA, Wood WG, Sun GY, Serfozo P, Simonyi A, Schachtman TR (2015) Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer\u2019s disease mouse model. J Alzheimers Dis 44:561\u2013572","journal-title":"J Alzheimers Dis"},{"key":"2492_CR196","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11010-013-1675-x","volume":"380","author":"N Jia","year":"2013","unstructured":"Jia N, Han K, Kong JJ, Zhang XM, Sha S, Ren GR, Cao YP (2013) (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP\/PS1 mice by restoring IRS-1 signaling defects in the hippocampus. Mol Cell Biochem 380:211\u2013218","journal-title":"Mol Cell Biochem"},{"key":"2492_CR197","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1523\/JNEUROSCI.6437-11.2012","volume":"32","author":"J Wang","year":"2012","unstructured":"Wang J, Ferruzzi MG, Ho L, Blount J, Janle EM, Gong B, Pan Y, Gowda GA, Raftery D, Arrieta-Cruz I, Sharma V, Cooper B, Lobo J, Simon JE, Zhang C, Cheng A, Qian X, Ono K, Teplow DB, Pavlides C, Dixon RA, Pasinetti GM (2012) Brain-targeted proanthocyanidin metabolites for Alzheimer\u2019s disease treatment. J Neurosci 32:5144\u20135150","journal-title":"J Neurosci"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-018-2492-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-2492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-2492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:53:08Z","timestamp":1751381588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-018-2492-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":197,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["2492"],"URL":"https:\/\/doi.org\/10.1007\/s11064-018-2492-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}